Fasting and nonfasting iodine-123-idophenylpentadecanoic acid myocardial SPECT imaging in coronary artery disease

G V Heller, A E Iskandrian, C Orlandi, A W Ahlberg, J Heo, A Mann, M P White, A Gagnon, R Taillefer
1998 Journal of Nuclear Medicine  
Iodine-123-labeled idophenylpentadecanoic acid (IPPA) metabolic imaging has been shown to be clinically useful for the identification of myocardial viability in patients with coronary artery disease and left ventricular dysfunction. Imaging is usually performed under fasting conditions since nonfasting conditions may affect myocardial uptake of 123I-IPPA. The purpose of this study was to examine the impact of dietary condition on 123I-IPPA metabolic imaging.
pmid:9867134 fatcat:7br65gym4ba3hm7mhklaqrfeoe